Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis

NCT00468208 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00468208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00468208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Lead sponsor
University of Pennsylvania
Phase
Phase 1/2
Overall status
Completed
Start date
February 29, 2008
Completion date
August 31, 2011
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

wegener's granulomatosis